Eye Health Supplements Market held USD 1.6 billion in 2020 and is to grow with a CAGR of 6.0% from 2020-2030. Eye wellbeing is going to become one of the main safety issues of modern era, and a significant attraction in nutraceuticals. Aging population, increasing screen exposure, poor nutritional habits and decreasing food quality all affect eye health worldwide with no prospect of trend-reversal. According to a study published in the newspaper New Media & Society in 2015, around 80 percent of European children have their own (smart)phones, and American children aged 8 to 10 spend about 6 hours each day using multimedia devices. Web search supplement interest has increased by 50 percent over the past five years, according to Google Trends. Approximately 1.3 billion people are living with some form of vision impairment, according to the World Health Organization (WHO). Uncoordinated refractive defects, ataractics, AMD, glaucoma, diabetic retinopathy, stiffness of the corn and trachoma are the leading triggers worldwide. WHO claims that 80% of all vision impairments can be prevented globally, because of available supplements and treatments which can prevent damage to eyes.
Market Dynamics and Factors:
Eye health supplements market growth is attributed to hectic diets and hazardous chemicals use will negatively impact people's eyesight, which is why they are compelled to aim for a healthier vision and desire to retain the ideal "20/20" eyesight has driven up demand for improved eye protection. The incidence of cataracts, macular degeneration, glaucoma and numerous other eye disorders causes patients to get their ophthalmologists recommend eye safety treatments. Vision doctors also advocate the importance of regularized use of eye safety treatments for visually disabled individuals in order to protect the majority of their eyesight. Major driving factors for the market also includes rapid government spending on the healthcare system, growing drugs production in developing and developed economies. Changing lifestyles of the population due to sudden spurt in cases of coronavirus in U.S., Brazil, India and China will foster eye health supplements market, since low immunity caused will certainly impact eye health. However, varying the prices of drug raw materials being supplied from China may restrain the growth of the market.
Market Segmentation:
Based on the type, the eye health supplements industry is segmented into antioxidant, fatty acids, anti-inflammatory supplements, neuro-protective supplements, others. Based on the application, the market is segmented into the eye health, diabetic retinopathy, macular degeneration, cataract, glaucoma and others. Geographical breakdown and analysis of each of the aforementioned segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.
Geographic Analysis:
Growing prevalence of eye disorders coupled with increasing understanding of eye health among consumers is expected to drive the market growth of eye health supplements over forecast periods. In addition, manufacturers' continued emphasis on developing formulation and clinical testing technologies for vision-control products is also responsible for remarkable growth in the industry. North America and Europe currently hold a large market share of global eye health supplements sector, and will continue to do so over the coming years with the introduction of numerous specialized eye health supplements.
Competitive Scenario:
Global Eye health supplements market, is highly competitive, consists of a few major players. In terms of market share, few of the major players currently dominate the market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this drug globally. Key players enhancing the global eye health supplements market size include Healths Harmony LLC (U.S), Bristol-Myers Squibb Company (U.S.), Vitabiotics Ltd. (U.K), Biosyntrx Inc. (U.S.), Nordic Naturals Inc. (U.S.), NUSAPURE (U.S.), and Bausch & Lomb Incorporated. (U.S.)
Eye Health Supplements Market Report Scope
Report Attribute | Details |
Analysis Period | 2020–2030 |
Base Year | 2021 |
Forecast Period | 2022–2030 |
Market Size Estimation | Billion (USD) |
Growth Rate (CAGR%) | 6 % |
| By Type (Antioxidant, Fatty acids, anti-inflammatory supplements, neuro-protective supplements), By Application (Eye Health, Macular Degeneration, Cataract, Diabetic Retinopathy, Glaucoma) |
Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
Key Companies Profiled | Healths Harmony LLC (U.S), Bristol-Myers Squibb Company (U.S.), Vitabiotics Ltd. (U.K), Biosyntrx Inc. (U.S.), Nordic Naturals Inc. (U.S.), NUSAPURE (U.S.), and Bausch & Lomb Incorporated. (U.S.) |